Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.

Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.

Bibliographic Details
Main Authors:	Slavin, S, Or, R, Naparstek, E, Weiss, L, Mumcuoglu, M, Weshler, Z, Brautbar, H, Cividalli, G, Glikson, M, Hale, G
Format:	Journal article
Language:	English
Published:	1987

Similar Items

PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA BY T-CELL DEPLETION INVITRO PRIOR TO TRANSPLANTATION
by: Slavin, S, et al.
Published: (1985)

New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantation.
by: Slavin, S, et al.
Published: (1986)

Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1.
by: Slavin, S, et al.
Published: (1985)

Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).
by: Waldmann, H, et al.
Published: (1984)

Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: graft-versus-host disease and graft-versus-leukemia effect.
by: Novitzky, N, et al.
Published: (1999)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
by: Naparstek, E, et al.
Published: (1993)

Ex vivo T-cell depletion of bone marrow grafts with campath 1 prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation.
by: Novitzky, N, et al.
Published: (1997)

T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
by: Novitzky, N, et al.
Published: (1997)

Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.
by: Cobbold, S, et al.
Published: (1986)

Development of murine model of allogeneic bone marrow transplantation and graft-versus-host disease
by: I. S. Moiseev, et al.
Published: (2016-12-01)

Acute graft-versus-host disease of the kidney in allogeneic rat bone marrow transplantation.
by: Seiichiro Higo, et al.
Published: (2014-01-01)

Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
by: Heit, W, et al.
Published: (1986)

T-CELL DEPLETION BY EXPOSURE TO CAMPATH-1G IN-VITRO PREVENTS GRAFT-VERSUS-HOST DISEASE
by: Jacobs, P, et al.
Published: (1994)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
by: Naparstek, E, et al.
Published: (1999)

T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease.
by: Jacobs, P, et al.
Published: (1994)

Chronic Graft versus Host Disease after Allogeneic Bone Marrow Transplantation; An Analysis of Incidence and Risk Factors.
by: A Ghavamzadeh, et al.
Published: (2004-03-01)

Chronic Graft versus Host Disease after Allogeneic Bone Marrow Transplantation; An Analysis of Incidence and Risk Factors.
by: Ghavamzadeh A, et al.
Published: (2004-07-01)

Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
by: Hale, G, et al.
Published: (1994)

In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.
by: Willemze, R, et al.
Published: (1992)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
by: Hale, G, et al.
Published: (1988)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
by: Yannouck F. van Lier, et al.
Published: (2023-12-01)

T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse.
by: Naparstek, E, et al.
Published: (1995)

Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults
by: Cosmin Tegla, et al.
Published: (2020-01-01)

"PREDICTIVE SIGNIFICANCE OF SERUM INTERLEUKIN-10 FOR ACUTE GRAFT VERSUS HOST DISEASE PRIOR TO ALLOGENEIC BONE MARROW TRASPLANTATION "
by: M. Iravani, et al.
Published: (2005-06-01)

Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.
by: Hale, G, et al.
Published: (1998)

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
by: Hale, G, et al.
Published: (2000)

Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease
by: Thomas Krüger, et al.
Published: (2022-10-01)

EPC infusion ameliorates acute graft-versus-host disease-related endothelial injury after allogeneic bone marrow transplantation
by: Weiwei Wang, et al.
Published: (2022-12-01)

Immunosuppressive Effects of Multipotent Mesenchymal Stromal Cells on Graft-Versus-Host Disease in Rats Following Allogeneic Bone Marrow Transplantation
by: Oral Nevruz, et al.
Published: (2013-09-01)

Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation
by: Eva A. S. Koster, et al.
Published: (2024-03-01)

What can be done to prevent graft versus host disease?
by: Waldmann, H, et al.
Published: (1994)

Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
by: Erika S Varady, et al.
Published: (2023-09-01)

Immune reconstitution following allogeneic bone marrow transplantation depleted of T-cells.
by: Davison, G, et al.
Published: (1998)

Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells.
by: Davison, G, et al.
Published: (2000)

Immune reconstitution post T-CELL depleted allogeneic bone marrow transplantation
by: Davison, G, et al.
Published: (1998)

Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
by: Peter Cuthbertson, et al.
Published: (2021-08-01)

Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in children
by: Y. V. Skvortsova, et al.
Published: (2016-12-01)

The role of pattern-recognition receptors in Graft-versus-host disease and Graft-versus-leukemia after allogeneic stem cell transplantation
by: Simon eHeidegger, et al.
Published: (2014-07-01)

Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.
by: Apperley, J, et al.
Published: (1986)

Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies
by: Simonetta Saldi, et al.
Published: (2022-12-01)